Teladoc Health (NYSE:TDOC) is set to report its third-quarter results on Wednesday, October 29, after the market close. Analysts expect the telehealth provider to post an adjusted loss of $0.23 per share on revenue of $634.86 million, representing a 0.9% year-over-year decline.
In the past three months, EPS estimates have seen seven upward and downward revisions, while revenue forecasts have been adjusted 10 times higher and 11 times lower, reflecting a mixed sentiment ahead of the report.
Investors will be watching for updates on Teladoc’s path to profitability and progress on cost optimization efforts amid a cooling post-pandemic telehealth demand.
Teladoc Health (NYSE:TDOC) has fallen 4.6% this year, underperforming the broader market’s 17.2% gain. Policy changes to Medicare and Medicaid, higher churn, and rising customer acquisition costs have added to ongoing headwinds amid weak telehealth demand and a lack of profitability.
That said, TDOC’s new management team has delivered promising early results from its repositioning efforts, reflected in the growing number of U.S. Integrated Care Members. The company is also expanding its vertically integrated healthcare offerings through recent acquisitions in at-home testing solutions and mental healthcare access within the insurance sector.
“The stock is likely to remain volatile moving forward, attributed to the still elevated short interest ratio of 13.1% despite the impacted stock price performance, worsened by the ongoing lack of adj EPS profitability as observed in the management’s FY2025 guidance at -$1.175 at the midpoint (+5.2% YoY),” said Seeking Alpha analyst Juxtaposed Ideas.